Petix & Botte Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Sell
710
-1,080
-60% -$252K 0.08% 101
2025
Q4
$370K Buy
1,790
+36
+2% +$7.12K 0.08% 96
2025
Q3
$325K Hold
1,754
0.08% 102
2025
Q2
$268K Hold
1,754
0.07% 115
2025
Q1
$291K Hold
1,754
0.08% 104
2024
Q4
$254K Hold
1,754
0.07% 113
2024
Q3
$284K Hold
1,754
0.08% 100
2024
Q2
$256K Sell
1,754
-718
-29% -$107K 0.07% 105
2024
Q1
$391K Buy
2,472
+718
+41% +$114K 0.1% 103
2023
Q4
$275K Sell
1,754
-50
-3% -$7.67K 0.08% 100
2023
Q3
$281K Sell
1,804
-260
-13% -$42.9K 0.09% 98
2023
Q2
$342K Buy
+2,064
New +$333K 0.11% 90
2022
Q2
Sell
-1,730
Closed -$307K 91
2022
Q1
$307K Buy
+1,730
New +$294K 0.09% 84
2021
Q4
Sell
-1,580
Closed -$255K 95
2021
Q3
$255K Buy
+1,580
New +$270K 0.09% 96

Other funds holding JNJ

Petix & Botte Financial's JNJ Position: Q1 2026 in Review

Petix & Botte Financial reduced its Johnson & Johnson (JNJ) stake by 60% in Q1 2026, selling an estimated $252K and leaving 710 shares worth $356K. The position accounts for 0.08% of the portfolio, ranked #101.

Petix & Botte Financial first reported a position in JNJ in Q3 2021 and has held it in 14 quarters since. The position peaked at $391K in Q1 2024. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Petix & Botte Financial held 710 shares of Johnson & Johnson worth $356K as of Q1 2026.
  • Petix & Botte Financial sold 1,080 Johnson & Johnson shares in Q1 2026, an estimated $252K.
  • Johnson & Johnson made up 0.08% of Petix & Botte Financial's portfolio in Q1 2026, its #101 holding.
  • Petix & Botte Financial first reported a position in Johnson & Johnson in Q3 2021 and has held it in 14 quarters since.
  • Petix & Botte Financial's Johnson & Johnson position peaked at $391K in Q1 2024.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Petix & Botte Financial's 13F filing for Q1 2026, filed 30 Apr 2026.